Advanced therapies. (2026, February 20). Public Health. https://health.ec.europa.eu/medicinal-products/product-types/advanced-therapies_en

American Cancer Society. (2025). What Is Immunotherapy? | Immunotherapy for Cancer. Www.cancer.org; American Cancer Society. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy.html 

Astrachan, M. (2019, January 29). Illustrating the Unconventional: PROTAC^TM Technology for Disease Therapy. XVIVO. https://xvivo.com/illustrating-the-unconventional-protac-technology-for-disease-therapy/  

Barot S, Patel H, Yadav A, Ban I. Recent advancement in targeted therapy and role of emerging technologies to treat cancer. Medical Oncology 2023 40:11. 2023 Oct 7;40(11):324-. doi:10.1007/s12032-023-02184-6 PubMed PMID: 37805624.

Beauchamp, T. L., & Childress, J. F. (2019). Principles of biomedical ethics (8th ed.). Oxford University Press.

Califf, R. M. (2018). Biomarker Definitions and Their Applications. Experimental Biology and Medicine, 243(3), 213–221. https://doi.org/10.1177/1535370217750088

Chacim S, Monjardino T, Cunha JL, Medeiros P, Redondo P, Bento MJ, et al. Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center. PLoS One. 2022 Dec 1;17(12):e0278950. doi:10.1371/JOURNAL.PONE.0278950 PubMed PMID: 36490296.

Collins, F. S. (2010). The language of life: DNA and the revolution in personalized medicine. HarperCollins.

Conselho da Europa. (1997). Convenção sobre os direitos do homem e a biomedicina (Convenção de Oviedo).

Costa, L. V., Caporossi, J. V. A., Enes, M. S. W., Freitas, V. K., & Bomfim, V. V. B. S. (2023). A importância da medicina personalizada na gestão de doenças cardiovasculares: avanços e aplicações clínicas. Revista Ibero-Americana de Humanidades, Ciências e Educação, 9(10), 5801–5808. https://doi.org/10.51891/rease.v9i10.12422

EAHP — European Association of Hospital Pharmacists. (2024a, August 21). EAHP. https://eahp.eu/policy-hub/atmps/

Enfermeriacelayane. (2019, 7 de janeiro). Unidad didáctica 3: Bioética. Licenciatura en Enfermería y Obstetricia, Universidad de Guanajuato. https://blogs.ugto.mx/enfermeriaenlinea/unidad-didactica-3-bioetica/

EUPATI – European Patients’ Academy on Therapeutic Innovation. (n.d.). Medicina estratificada vs medicina personalizada. https://toolbox.eupati.eu/resources/medicina-estratificada-vs-medicina-personalizada/?lang=pt-pt (Acesso em 26 de abril de 2026).

European Medicines Agency. (n.d.). Advanced therapy medicinal products: Overview | European Medicines Agency. Www.ema.europa.eu. https://www.ema.europa.eu/en/human-regulatory-overview/advanced-therapy-medicinal-products-overview

FDA-NIH Biomarker Working Group. (2011). BEST (Biomarkers, EndpointS, and other Tools) Resource. https://www.ncbi.nlm.nih.gov/books/NBK326791/pdf/Bookshelf_NBK326791.pdf

Huang J, Xiang Y, Gan S, Wu L, Yan J, Ye D, et al. Application of artificial intelligence in medical imaging for tumor diagnosis and treatment: a comprehensive approach. Discover Oncology 2025 16:1. 2025 Aug 26;16(1):1625-. doi:10.1007/s12672-025-03307-3

Iancu, D. (2018). Genomic Editing—From Human Health to the “Perfect Child.” Clinical Ethics at the Crossroads of Genetic and Reproductive Technologies, 1–30. https://doi.org/10.1016/b978-0-12-813764-2.00001-5 

Kim, H., & Park, K. U. (2023). Clinical Circulating Tumor DNA Testing for Precision Oncology. Cancer Research and Treatment, 55(2), 351–366. https://doi.org/10.4143/crt.2022.1026 

Lei n.º 12/2005, de 26 de janeiro. (2005). Lei da Informação Genética e Proteção da Saúde. Diário da República.

Lin, D., Shen, L., Luo, M., Zhang, K., Li, J., Yang, Q., Zhu, F., Zhou, D., Zheng, S., Chen, Y., & Zhou, J. (2021). Circulating tumor cells: biology and clinical significance. Signal Transduction and Targeted Therapy, 6(1), 1–24. https://doi.org/10.1038/s41392-021-00817-8 

Lorentzen, A. L. (2022, September 26). What is ctDNA? DCCC CtDNA Center. https://ctdna.dk/research/the-research/what-is-ctdna 

Louie, A. D., Huntington, K., Carlsen, L., Zhou, L., & El-Deiry, W. S. (2021). Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.747194 

Ma R, Li Z, Chiocca EA, Caligiuri MA, Yu J. The emerging field of oncolytic virus-based cancer immunotherapy. Trends Cancer. 2022 Feb 1;9(2):122. doi:10.1016/J.TRECAN.2022.10.003 PubMed PMID: 36402738. 

Medeiros, A. M., Alves, A. C., Francisco, V., & Bourbon, M. (2011). Estudo Português de Hipercolesterolemia Familiar. Insa.pt; Instituto Nacional de Saúde Doutor Ricardo Jorge, IP. https://repositorio.insa.pt/entities/publication/6983408e-888c-46b4-8bd7-f7cdc1711ae0

Medicina personalizada – INSA. (2017). Instituto Nacional de Saúde Doutor Ricardo Jorge. https://www.insa.min-saude.pt/medicina-personalizada/

MedlinePlus. (2022b, March 22). What Are Genome Editing and CRISPR-Cas9? Medlineplus; National Library of Medicine. https://medlineplus.gov/genetics/understanding/genomicresearch/genomeediting/ 

National Cancer Institute. (2019a, September 24). Immune System Modulators for Cancer Therapy – National Cancer Institute. Www.cancer.gov; National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/immune-system-modulators 

National Cancer Institute. (2019b, September 24). Immunotherapy to Treat Cancer. National Cancer Institute; Cancer.gov. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy 

National Center for Biotechnology Information. (n.d.). PMC6856032. https://pmc.ncbi.nlm.nih.gov/articles/PMC6856032/

National Center for Biotechnology Information. (n.d.). PMC6996905. https://pmc.ncbi.nlm.nih.gov/articles/PMC6996905/

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research.

National Library of Medicine. (2007). Understanding Human Genetic Variation. Nih.gov; National Institutes of Health (US). https://www.ncbi.nlm.nih.gov/books/NBK20363/

Pei H, Peng Y, Zhao Q, Chen Y. Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery. RSC Adv. 2019 May 30;9(30):16967–76. doi:10.1039/c9ra03423d

Pouwels XGLV, Ramaekers BLT, Joore MA. Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer. Breast Cancer Res Treat. 2017 Oct 1;165(3):485. doi:10.1007/S10549-017-4374-6 PubMed PMID: 28689361.

ResearchGate. (n.d.). The representative immunohistochemistry (IHC) results of ER, PR and HER-2 expression. https://www.researchgate.net/figure/The-representative-immunohistochemistry-IHC-results-of-ER-PR-and-HER-2-expression-in_fig1_318437701

Rothstein, M. A. (2018). Genetics and the workplace: Ethical, legal, and social challenges.

SA, L. C. (2023, July 27). DNA circulante tumoral (ctDNA) – Sociedade Portuguesa de Gastrenterologia. Sociedade Portuguesa de Gastrenterologia – Mais Um Site WordPress. https://www.spg.pt/sabia-que/dna-circulante-tumoral-ctdna/

Seara.com. (2024). Webinar “Terapias Avançadas.” Ordem Dos Farmacêuticos. https://ordemfarmaceuticos.pt/pt/eventos/webinar-terapias-avancadas/

Shiravand, Y., Khodadadi, F., Kashani, S. M. A., Hosseini-Fard, S. R., Hosseini, S., Sadeghirad, H., Ladwa, R., O’Byrne, K., & Kulasinghe, A. (2022). Immune Checkpoint Inhibitors in Cancer Therapy. Current Oncology (Toronto, Ont.), 29(5), 3044–3060. https://doi.org/10.3390/curroncol29050247

Torres Moral, T., Sanchez-Niubo, A., Monistrol-Mula, A., Gerardi, C., Banzi, R., Garcia, P., Demotes-Mainard, J., Haro, J. M., & PERMIT Group. (2022). Methods for stratification and validation cohorts: a scoping review. Journal of Personalized Medicine, 12(5), 688. https://doi.org/10.3390/jpm12050688

Translational medicine in Familial hypercholesterolaemia – the Portuguese FH Study – ICPerMed. (2024, February 20). ICPerMed. https://www.icpermed.eu/icpermed/best-practice-examples/translational-medicine-in-familial-hypercholesterolaemia/

UNESCO. (2005). Universal declaration on bioethics and human rights.

Vellekoop H, Versteegh M, Huygens S, Corro Ramos I, Szilberhorn L, Zelei T, et al. The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis. Value in Health. 2022 Aug 1;25(8):1428–38. doi:10.1016/J.JVAL.2022.01.006 PubMed PMID: 35248467.

Verma V, Sprave T, Haque W, Simone CB, Chang JY, Welsh JW, et al. A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer 2018 6:1. 2018 Nov 23;6(1):128-. doi:10.1186/S40425-018-0442-7 PubMed PMID: 30470252.

Visvikis-Siest, S., Theodoridou, D., Kontoe, M.-S., Kumar, S., & Marschler, M. (2020). Milestones in Personalized Medicine: From the Ancient Time to Nowadays—the Provocation of COVID-19. Frontiers in Genetics, 11. https://doi.org/10.3389/fgene.2020.569175

Wang, X., Huang, J., Chen, W., Li, G., Li, Z., & Lei, J. (2022). The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer. Experimental & Molecular Medicine, 54(9), 1390–1400. https://doi.org/10.1038/s12276-022-00855-4 

Wang, X., Tian, L., Lu, J., & Ng, I. O.-L. (2022). Exosomes and cancer – Diagnostic and prognostic biomarkers and therapeutic vehicle. Oncogenesis, 11(1), 1–12. https://doi.org/10.1038/s41389-022-00431-5 

Yang, S., Hu, H., Kung, H., Zou, R., Dai, Y., Hu, Y., Wang, T., Lv, T., Yu, J., & Li, F. (2023). Organoids: The current status and biomedical applications. MedComm, 4(3), e274. https://doi.org/10.1002/mco2.274     

Yang J, Huang J, Han D, Ma X. Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review. Clin Med Insights Oncol. 2024 Jan 1;18. doi:10.1177/11795549231220320

Zugasti, I., Espinosa-Aroca, L., Fidyt, K., Mulens-Arias, V., Diaz-Beya, M., Juan, M., Urbano-Ispizua, Á., Esteve, J., Velasco-Hernandez, T., & Menéndez, P. (2025). CAR-T cell therapy for cancer: current challenges and future directions. Signal Transduction and Targeted Therapy, 10(1). https://doi.org/10.1038/s41392-025-02269-w